Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam flag Vietnam · Delayed Price · Currency is VND
60,700
+200 (0.33%)
At close: Aug 28, 2026

HNX:DP3 Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Net Income
173,966156,073121,172125,263108,82494,305
Depreciation & Amortization
18,16312,40112,94113,980--
Other Amortization
8080----
Loss (Gain) From Sale of Assets
-22,864-22,864-15,492-21,684--
Other Operating Activities
-68,2595,366-1,0414,079-9,609-67,997
Change in Accounts Receivable
-3,296-3,296-24,07613,163--
Change in Inventory
-12,741-12,7418,40617,504--
Change in Accounts Payable
17,04117,041-10,859-414.91--
Change in Other Net Operating Assets
-553.55-553.55866.971,211--
Operating Cash Flow
101,536151,50791,917153,10299,21526,308
Operating Cash Flow Growth
-32.86%64.83%-39.96%54.31%277.13%-78.50%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Capital Expenditures
-7,588-7,588-1,465-6,403-15,089-446.26
Sale of Property, Plant & Equipment
3030269.411,824--
Other Investing Activities
22,73119,99416,85217,5218,8146,324
Investing Cash Flow
-26,537-130,566-11,330-102,680-54,65425,878

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Short-Term Debt Issued
----15,41410,210
Long-Term Debt Issued
-91,17210,10015,110--
Total Debt Issued
91,17291,17210,10015,11015,41410,210
Short-Term Debt Repaid
-----12,222-12,060
Long-Term Debt Repaid
--56,899-17,875-12,565-1,490-
Total Debt Repaid
-101,201-56,899-17,875-12,565-13,712-12,060
Net Debt Issued (Repaid)
-10,02934,273-7,7752,5451,702-1,850
Common Dividends Paid
-64,434-64,444-64,481-68,698-49,885-66,529
Financing Cash Flow
-74,463-30,171-72,256-66,153-48,183-68,379

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.910.050.270.7225.842.48
Net Cash Flow
535.3-9,2318,331-15,731-3,596-16,191

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Free Cash Flow
93,947143,91990,452146,69984,12625,862
Free Cash Flow Growth
-37.27%59.11%-38.34%74.38%225.29%-52.21%
Free Cash Flow Margin
18.22%32.86%21.67%35.80%17.34%6.79%
Free Cash Flow Per Share
4369.656693.914207.106823.213717.111202.91
Levered Free Cash Flow
73,421112,87777,061127,65060,23055,727
Unlevered Free Cash Flow
74,339113,31177,162128,64664,27756,008

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Cash Interest Paid
1,462679.56188.51,5672,8681,207
Cash Income Tax Paid
36,11531,17931,74027,66524,15929,399
Change in Working Capital
450.61450.61-25,66231,463--